Amphastar Pharmaceuticals (AMPH) EBT (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly EBT of $10.1 million for Q1 2026, down 67.43% year-over-year from $30.9 million in Q1 2025, and down 68.5% quarter-over-quarter from $31.9 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) EBT (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' EBT history runs 14 years deep, the most recent figure standing at $10.1 million for Q1 2026.
- In Q1 2026, EBT fell 67.43% year-over-year to $10.1 million; the TTM figure through Mar 2026 stood at $102.8 million (down 40.48% YoY), while the FY2025 annual figure was $123.6 million, down 34.85% from the prior year.
- EBT for Q1 2026 stood at $10.1 million, down from $31.9 million in the prior quarter.
- The five-year high for EBT was $63.6 million in Q3 2023, with the low at -$140.6 million in Q4 2023.
- The 5-year median for EBT is $32.8 million (2023), against an average of $25.2 million.
- The sharpest annual moves came in 2022 and 2023: EBT surged 467.72% in 2022, then plunged 440.71% in 2023.
- Amphastar Pharmaceuticals' EBT stood at $41.3 million in 2022, then slumped by 440.71% to -$140.6 million in 2023, then surged by 131.27% to $44.0 million in 2024, then dropped by 27.41% to $31.9 million in 2025, then slumped by 68.5% to $10.1 million in 2026.
- Business Quant data shows AMPH's EBT at $10.1 million in Q1 2026, $31.9 million in Q4 2025, and $21.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.40 Bn | 39.75 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.85 Bn | 30.18 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.88 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.68 Bn | 15.29 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 932.67 Mn | 642.55 Mn | 93.47 Mn | 38.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.54 Mn |
| Mar 31, 2026 | 10.05 Mn |
| Dec 31, 2025 | 31.91 Mn |
| Sep 30, 2025 | 21.51 Mn |
| Jun 30, 2025 | 39.34 Mn |
| Mar 31, 2025 | 30.86 Mn |
| Dec 31, 2024 | 43.96 Mn |
| Sep 30, 2024 | 47.68 Mn |
| Jun 30, 2024 | 50.24 Mn |
| Mar 31, 2024 | 47.88 Mn |
| Dec 31, 2023 | -140.58 Mn |
| Sep 30, 2023 | 63.64 Mn |
| Jun 30, 2023 | 32.81 Mn |
| Mar 31, 2023 | 33.57 Mn |
| Dec 31, 2022 | 41.26 Mn |
| Sep 30, 2022 | 22.60 Mn |
| Jun 30, 2022 | 23.15 Mn |
| Mar 31, 2022 | 29.03 Mn |
| Dec 31, 2021 | 27.16 Mn |
| Sep 30, 2021 | 37.65 Mn |